Vertex Pharmaceuticals, Inc. (NASDAQ:VRTX)

murr2006 (< 20) Submitted: 8/23/2006 9:18:12 PM : Start Price: $32.83 VRTX Score: +89.28

Break throughs in several new drugs and the recent stock buyout of long term debt of 51M pits this small drug company in a position to grow at a very fast pace in relation to other older and larger drug manufacturers.

mansloth (97.26) Submitted: 8/21/2006 3:23:34 AM : Start Price: $32.42 VRTX Score: +91.76

Seems to have the pipeline, the partnerships, and the cash to grow into a much larger company.

Price seems a bit rich now, and in fact I wouldn't be surprized to see the stock dip some in the coming year. However, as time goes by and the products advance through clinicals, today's price may look like a bargain.

iksnamyzs (75.48) Submitted: 6/28/2006 11:25:42 PM : Start Price: $30.12 VRTX Score: +102.82

TMFbreaker Charly pick

RBBioContest06 (54.27) Submitted: 5/31/2006 10:31:45 PM : Start Price: $34.50 VRTX Score: +76.94

Picked by 123buy

Unklesam101 (37.47) Submitted: 5/31/2006 6:11:41 PM : Start Price: $33.81 VRTX Score: +80.68

I have owned this Co for 6 years. I believe in another 6 it could be well North of current valuation. Its HCV compound is so far "Best in Class."-

TMFBreakerBrian (99.77) Submitted: 5/30/2006 12:42:13 PM : Start Price: $33.58 VRTX Score: +82.51

While VX-950 won't be on the market until 2008 at the earliest, the potential of this drug to dominate the multibilion dollar HCV market is huge after near 100% responses in the 2 phase I trials. Charly did great with this Rule Breaker pick.